About this trial
Acute muscle strain injuries occur both during sports, in leisure time activities and during manual occupation and represent a major clinical challenge and has societal economic costs. The recovery time is long and a substantial injury recurrence is observed. Despite current best evidence rehabilitation with early mechanical loading, a significant loss of muscle mass, fatty infiltration and formation of scar tissue is reported.
Animal models and human in vitro experiments suggest that inflammation is vital in the early period after an injury, however an inhibition of inflammatory processes is beneficial for healing.
We investigate here whether a pharmacological inhibition of inflammatory pathways in the 2nd week following a muscle strain injury will provide a better clinical outcome and an advantageous cellular profile than rehabilitative training alone would.
Eligibility criteria
Qualifiers
Sports-active individuals with an acute muscle train injury in either the hamstrings or calf muscle caused by an explosive movement (during sprinting, jumping etc)
Age older than 18 years
Disqualifiers
Lack of hypoechoic/ hyperechoic area on ultrasound
Diabetes type I and II
Connective tissue disorders, rheumatism or any other chronic disease affecting the musculoskeletal system
Anticoagulant medication
Trial design
Treatments tested in this trial
- Naproxen 500 Mg
- Rehabilitation
- Placebo